Michigan Biosciences Industry Association Logo

Federal Advocacy

Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
Bill to Reauthorize the Rare Pediatric Disease PRV Program Introduced
Posted In: Federal Advocacy,
Date posted Mar 27

Bipartisan Effort Revives Rare Pediatric Disease Program The bipartisan “Give Kids a Chance Act of 2025”, or H.R. 1262, was...

Read Post
MichBio Continues to Push Back on Proposed NIH Cuts
Posted In: Federal Advocacy, MichBio News/Statement,
Date posted Mar 27

Defending Biomedical Innovation Amid NIH Budget Threats MichBio, along with numerous other bio-industry groups, continues to press Congress and...

Read Post
Epic Act Reintroduced
Posted In: Federal Advocacy,
Date posted Mar 4

Discover MichBio, Michigan's bioscience industry leader. Explore membership benefits, events, advocacy efforts, and the latest news on drug...

Read Post
MichBio Talks Medtech with Michigan Congressional Delegation
Posted In: Federal Advocacy,
Date posted Mar 4

Join MichBio in advocating for the medtech industry! Discover our initiatives, events, and membership benefits to support innovation in Michigan's...

Read Post
NIH Indirect Cost Cuts Risks U.S. Leadership in Life Science Innovation
Posted In: Federal Advocacy,
Date posted Mar 4

Discover how NIH funding cuts threaten U.S. leadership in life science innovation. MichBio advocates for research sustainability and economic growth.

Read Post
Getting Involved: Contacting Your Michigan Congressional Office
Posted In: Federal Advocacy,
Date posted Feb 11

Advocate for bioscience funding in Michigan! Learn how to contact your Congressional representatives and support vital biomedical research...

Read Post
Federal Advocacy Outlook 2025: Early 2025
Posted In: Federal Advocacy,
Date posted Jan 22

Explore MichBio's insights on federal advocacy for 2025, focusing on policy impacts, tax reforms, and industry growth strategies in the biosciences...

Read Post
Attempts to Regulate Drug Pricing Fail During Legislative Chaos
Posted In: Federal Advocacy,
Date posted Dec 31

Discover the latest on drug pricing reforms in Michigan, including legislative challenges and opposition from key industry groups like MichBio and...

Read Post
Biosecure Act Fails to be Enacted
Posted In: Federal Advocacy,
Date posted Dec 31

Stay updated on the BIOSECURE Act's challenges in Congress and its implications for U.S. biotech. Learn more about MichBio's advocacy efforts.

Read Post
CMS Finalizes Accelerated Approval Pathway for Devices
Posted In: Federal Advocacy,
Date posted Dec 31

Explore MichBio's resources for the bio-industry, including membership benefits, events, advocacy, and the latest news on medical technology...

Read Post
Ensuring Patient Access to Critical Breakthrough Products
Posted In: Federal Advocacy,
Date posted Dec 31

Stay informed on the "Ensuring Patient Access to Critical Breakthrough Products Act," aimed at expediting Medicare coverage for innovative medical...

Read Post
Section 174 Struggles Persist: Advocacy Pushes for Relief
Posted In: Federal Advocacy,
Date posted Dec 31

Stay updated on MichBio's advocacy efforts for R&D tax relief and the impact of Section 174 on life science companies. Join us in pushing for change!

Read Post